Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2/Neu Positive|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Epirubicin Hydrochloride|OTHER: Laboratory Biomarker Analysis|DRUG: Paclitaxel|PROCEDURE: Therapeutic Conventional Surgery|BIOLOGICAL: Trastuzumab
Sponsor: National Cancer Institute (NCI)